DIFFERING STRUCTURAL REQUIREMENTS FOR GTPASE-ACTIVATING PROTEIN RESPONSIVENESS AND NADPH OXIDASE ACTIVATION BY RAC

被引:0
|
作者
XU, XM
BARRY, DC
SETTLEMAN, J
SCHWARTZ, MA
BOKOCH, GM
机构
[1] Scripps Res Inst, DEPT IMMUNOL, LA JOLLA, CA 92037 USA
[2] Scripps Res Inst, DEPT CELL BIOL, LA JOLLA, CA 92037 USA
[3] Scripps Res Inst, DEPT VASC BIOL, LA JOLLA, CA 92037 USA
[4] HARVARD UNIV, MASSACHUSETTS GEN HOSP, SCH MED, CTR CANC, BOSTON, MA 02129 USA
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Rac GTP-binding proteins regulate the actin cytoskeleton and the superoxide-forming NADPH oxidase of phagocytic leukocytes. These functions of Rac are determined by the GTP/GDP state of the protein, which can be modulated by GTPase-activating proteins (GAPs). The interaction of Ras with both downstream signaling targets and GAPs is mediated via an ''effector'' domain (amino acids 3(9-40). We demonstrate that the effector domain of Rac2 is required for both NADPH oxidase activation and actin assembly, but that mutations in this region do not decrease the responsiveness of Rac to GAPs. In contrast, mutations of residues 12 (Gly --> Val) or 61 (Gln --> Leu) inhibit both intrinsic- and GAP-stimulated GTP hydrolysis by Rac2. A double mutation in which both the effector domain and Q61L were modified restored NADPH oxidase activation and membrane ruffling, while the equivalent effector domain and G12V double mutation did not. The Rac2 Q61L mutant had an increased ''affinity'' for NADPH oxidase activation and for GAP binding as compared to the wild type or G12V proteins. These experiments suggest that Rac contains at least two ''effector'' interaction sites, and that changes in binding interactions at one of these sites may influence the function of the other.
引用
收藏
页码:23569 / 23574
页数:6
相关论文
共 50 条
  • [1] REGULATION OF NADPH OXIDASE ACTIVITY BY RAC GTPASE-ACTIVATING PROTEIN(S)
    HEYWORTH, PG
    KNAUS, UG
    SETTLEMAN, J
    CURNUTTE, JT
    BOKOCH, GM
    MOLECULAR BIOLOGY OF THE CELL, 1993, 4 (11) : 1217 - 1223
  • [2] Participation of Rac GTPase activating proteins in the deactivation of the phagocytic NADPH oxidase
    Moskwa, P
    Dagher, MC
    Paclet, MH
    Morel, F
    Ligeti, E
    BIOCHEMISTRY, 2002, 41 (34) : 10710 - 10716
  • [3] BCR ENCODES A GTPASE-ACTIVATING PROTEIN FOR P21RAC
    DIEKMANN, D
    BRILL, S
    GARRETT, MD
    TOTTY, N
    HSUAN, J
    MONFRIES, C
    HALL, C
    LIM, L
    HALL, A
    NATURE, 1991, 351 (6325) : 400 - 402
  • [4] Role of Rac GTPase activating proteins in regulation of NADPH oxidase in human neutrophils
    Lorincz, Akos M.
    Szarvas, Gabor
    Smith, Susan M. E.
    Ligeti, Erzsebet
    FREE RADICAL BIOLOGY AND MEDICINE, 2014, 68 : 65 - 71
  • [5] Regulation of the phagocyte NADPH oxidase by Rac GTPase
    Bokoch, Gary M.
    Zhao, Tieming
    ANTIOXIDANTS & REDOX SIGNALING, 2006, 8 (9-10) : 1533 - 1548
  • [6] Ras GTPase-activating protein binds to Akt and is required for its activation
    Yue, YZ
    Lypowy, J
    Hedhli, N
    Abdellatif, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (13) : 12883 - 12889
  • [7] Down-Regulation of Rac GTPase-Activating Protein OCRL1 Causes Aberrant Activation of Rac1 in Osteoarthritis Development
    Zhu, Shouan
    Dai, Jun
    Liu, Huanhuan
    Cong, Xiaoxia
    Chen, Yishan
    Wu, Yan
    Hu, Hu
    Heng, Boon Chin
    Ouyang, Hong Wei
    Zhou, Yiting
    ARTHRITIS & RHEUMATOLOGY, 2015, 67 (08) : 2154 - 2163
  • [8] Clinical value of Rac GTPase-activating protein 1 (RACGAP1) in esophageal carcinoma
    Okugawa, Yoshinaga
    Kitajima, Takahito
    Shimura, Tadanobu
    Toiyama, Yuji
    CANCER SCIENCE, 2023, 114 : 1011 - 1011
  • [9] CdGAP, a novel proline-rich GTPase-activating protein for Cdc42 and Rac
    Lamarche-Vane, N
    Hall, A
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (44) : 29172 - 29177
  • [10] Rac GTPase-Activating Protein 1 (RACGAP1) as an Oncogenic Enhancer in Esophageal Carcinoma
    Yin, Chengzeng
    Toiyama, Yuji
    Okugawa, Yoshinaga
    Shigemori, Tsunehiko
    Yamamoto, Akira
    Ide, Shozo
    Kitajima, Takahito
    Fujikawa, Hiroyuki
    Yasuda, Hiromi
    Okita, Yoshiki
    Hiro, Junichiro
    Yoshiyama, Shigeyuki
    Ohi, Masaki
    Araki, Toshimitsu
    Yao, Li
    Kusunoki, Masato
    ONCOLOGY, 2019, 97 (03) : 155 - 163